Clinical Trials Update: July 28, 2005
Irritable Bowel Syndrome (IBS) Eczema (Atopic Dermatitis) Cancer/Tumors
(HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch:
Irritable Bowel Syndrome (IBS)
If you have experienced constipation-related IBS during the past year, this study will evaluate an investigational medication to see if it relieves the symptoms of IBS. If you qualify, you will receive all study-related care, examinations, laboratory services, and study medication. Research site located in Chaska, MT.
Eczema (Atopic Dermatitis)
Volunteers are needed for an atopic dermatitis (eczema) study. Qualified participants must be 12 years or older and diagnosed with moderate-to-severe atopic dermatitis. The study length is about 4 weeks, requiring 4 visits (screen, treatment visits, and a follow-up visit). Participants will receive either investigational study drug or placebo (something that looks like the study drug but does not have the active ingredient). Research site located in New Brunswick, NJ.
BAY 43-9006 is an investigational drug being studied as a potential treatment for hepatocellular carcinoma. 100554 (A Phase III randomized, placebo-controlled study of sorafenib in patients with advanced hepatocellular carcinoma is being conducted in 23 countries to evaluate the safety and efficacy of BAY 43-9006. Participants must be male or female at least 18 years of age and have a life expectancy of at least 12 weeks. Research site located in Detroit, Mich.
Copyright 2005 CenterWatch. All rights reserved.